Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Ozen A, Kasap N, Vujkovic-Cvijin I, et al. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease. Nat Immunol. 2021;22(2):128–39.
2. Hill A, DeZern AE, Kinoshita T, et al. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017;3:17028.
3. Ozen A, Comrie WA, Ardy RC, et al. CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis. N Engl J Med. 2017;377(1):52–61.
4. Ozen A, Lenardo MJ. Protein-losing enteropathy. N Engl J Med. 2023;389(8):733–48.
5. Regeneron Pharmaceuticals Inc. VEOPOZ (pozelimab-bbfg) injection, for intravenous or subcutaneous use: US prescribing information. 2023. https://www.fda.gov/. Accessed 23 Aug 2023.